End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28,500 KRW | +0.18% | +0.35% | +2.70% |
2023 | Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index | CI |
2023 | Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Sales 2024 * | 213B 157M | Sales 2025 * | 233B 171M | Capitalization | 168B 123M |
---|---|---|---|---|---|
Net income 2024 * | 30B 22.08M | Net income 2025 * | 33B 24.29M | EV / Sales 2024 * | 0.14 x |
Net cash position 2024 * | 138B 102M | Net cash position 2025 * | 163B 120M | EV / Sales 2025 * | 0.02 x |
P/E ratio 2024 * |
5.55
x | P/E ratio 2025 * |
5.15
x | Employees | 553 |
Yield 2024 * |
2.46% | Yield 2025 * |
2.54% | Free-Float | 59.32% |
1 day | +0.18% | ||
1 week | +0.35% | ||
Current month | +0.18% | ||
1 month | +1.42% | ||
6 months | +4.40% | ||
Current year | +2.70% |
Managers | Title | Age | Since |
---|---|---|---|
Yoon-Woo Lee
CEO | Chief Executive Officer | 80 | 69-06-30 |
Dong-Il Lee
BRD | Director/Board Member | 71 | 02-02-28 |
Seong-Soo Yoon
AUD | Comptroller/Controller/Auditor | 46 | 17-03-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yoon-Woo Lee
CEO | Chief Executive Officer | 80 | 69-06-30 |
Seung-Young Lee
BRD | Director/Board Member | 51 | 02-02-28 |
Dong-Il Lee
BRD | Director/Board Member | 71 | 02-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 28,500 | +0.18% | 4,923 |
24-05-02 | 28,450 | 0.00% | 2,874 |
24-04-30 | 28,450 | +0.18% | 5,981 |
End-of-day quote Korea S.E., May 02, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.70% | 124M | |
+21.55% | 43.95B | |
+21.63% | 22.49B | |
+14.56% | 14.71B | |
+12.18% | 13.77B | |
+44.52% | 12.3B | |
-8.66% | 7.03B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.75% | 5.48B |
- Stock Market
- Equities
- A023910 Stock